Guided Therapeutics (GTHP) Shares Outstanding (2016 - 2025)
Historic Shares Outstanding for Guided Therapeutics (GTHP) over the last 16 years, with Q3 2025 value amounting to $83599.0.
- Guided Therapeutics' Shares Outstanding fell 9986.17% to $83599.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $83599.0, marking a year-over-year decrease of 9986.17%. This contributed to the annual value of $65131.0 for FY2024, which is 9987.96% down from last year.
- Per Guided Therapeutics' latest filing, its Shares Outstanding stood at $83599.0 for Q3 2025, which was up 3827.84% from $78971.0 recorded in Q2 2025.
- Guided Therapeutics' Shares Outstanding's 5-year high stood at $78.0 million during Q1 2025, with a 5-year trough of $286.0 in Q4 2024.
- Its 5-year average for Shares Outstanding is $25.4 million, with a median of $13.7 million in 2021.
- Its Shares Outstanding has fluctuated over the past 5 years, first crashed by 9988.97% in 2024, then soared by 14025104.59% in 2025.
- Over the past 5 years, Guided Therapeutics' Shares Outstanding (Quarter) stood at $13.7 million in 2021, then surged by 255.41% to $48.6 million in 2022, then plummeted by 99.89% to $54105.0 in 2023, then rose by 20.38% to $65131.0 in 2024, then increased by 28.36% to $83599.0 in 2025.
- Its Shares Outstanding was $83599.0 in Q3 2025, compared to $79.0 million in Q2 2025 and $78.0 million in Q1 2025.